115 related articles for article (PubMed ID: 10833512)
21. Pulmonary toxicity associated with fludarabine monophosphate.
Hurst PG; Habib MP; Garewal H; Bluestein M; Paquin M; Greenberg BR
Invest New Drugs; 1987; 5(2):207-10. PubMed ID: 2443463
[TBL] [Abstract][Full Text] [Related]
22. Excision of beta-D- and beta-L-nucleotide analogs from DNA by the human cytosolic 3'-to-5' exonuclease.
Pelicano H; Kukhanova M; Cheng YC
Mol Pharmacol; 2000 May; 57(5):1051-5. PubMed ID: 10779391
[TBL] [Abstract][Full Text] [Related]
23. Effects of deoxyadenosine triphosphate and 9-beta-D-arabinofuranosyl-adenine 5'-triphosphate on human ribonucleotide reductase from Molt-4F cells and the concept of "self-potentiation".
Chang CH; Cheng YC
Cancer Res; 1980 Oct; 40(10):3555-8. PubMed ID: 6159965
[TBL] [Abstract][Full Text] [Related]
24. Differential inhibition of mammalian DNA polymerases alpha, beta and gamma and herpes simplex virus-induced DNA polymerase by the 5'-triphosphates of arabinosyladenine and arabinosylcytosine.
Reinke CM; Drach JC; Shipman C; Weissbach A
IARC Sci Publ (1971); 1978; (24 Pt 2):999-1005. PubMed ID: 87370
[No Abstract] [Full Text] [Related]
25. Inhibition of nuclear envelope nucleoside triphosphatase-regulated nucleocytoplasmic messenger RNA translocation by 9-beta-D-arabinofuranosyladenine 5'-triphosphate in rodent cells.
Schröder HC; Nitzgen DE; Bernd A; Kurelec B; Zahn RK; Gramzow M; Müller WE
Cancer Res; 1984 Sep; 44(9):3812-9. PubMed ID: 6204747
[TBL] [Abstract][Full Text] [Related]
26. A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluids.
Kemena A; Fernandez M; Bauman J; Keating M; Plunkett W
Clin Chim Acta; 1991 Aug; 200(2-3):95-106. PubMed ID: 1723357
[TBL] [Abstract][Full Text] [Related]
27. Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells.
Rustum YM; Mayhew E; Szoka F; Campbell J
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):809-17. PubMed ID: 7199474
[No Abstract] [Full Text] [Related]
28. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
Avramis VI
Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity.
Leiby JM; Snider KM; Kraut EH; Metz EN; Malspeis L; Grever MR
Cancer Res; 1987 May; 47(10):2719-22. PubMed ID: 2436757
[TBL] [Abstract][Full Text] [Related]
30. Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.
Jamieson GP; Finch LR; Snook M; Wiley JS
Cancer Res; 1987 Jun; 47(12):3130-5. PubMed ID: 3472653
[TBL] [Abstract][Full Text] [Related]
31. Endo-exonuclease of human leukaemic cells: evidence for a role in apoptosis.
Fraser MJ; Tynan SJ; Papaioannou A; Ireland CM; Pittman SM
J Cell Sci; 1996 Sep; 109 ( Pt 9)():2343-60. PubMed ID: 8886984
[TBL] [Abstract][Full Text] [Related]
32. More on purine analog-induced apoptosis in B cell chronic lymphocytic leukemia.
Morabito F; Filangeri M; Sculli G; Oliva B
Leukemia; 1998 Apr; 12(4):633-5. PubMed ID: 9557625
[No Abstract] [Full Text] [Related]
33. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
34. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.
Lilling G; Elena N; Sidi Y; Bakhanashvili M
Oncogene; 2003 Jan; 22(2):233-45. PubMed ID: 12527892
[TBL] [Abstract][Full Text] [Related]
35. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
Shewach DS; Plunkett W
Biochem Pharmacol; 1982 Jun; 31(11):2103-9. PubMed ID: 6180754
[No Abstract] [Full Text] [Related]
36. Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
Higashigawa M; Hori H; Ohkubo T; Kawasaki H; Yoshizumi T; Sakurai M
Med Oncol Tumor Pharmacother; 1990; 7(4):223-6. PubMed ID: 2283889
[TBL] [Abstract][Full Text] [Related]
37. A human B-cell CLL model established by transplantation of JOK-1 cells into SCID mice and an anti-leukemia efficacy of fludarabine phosphate.
Bai L; Kon K; Tatsumi M; Ito H; Hayashi S; Brautigam M
Oncol Rep; 2000; 7(1):33-8. PubMed ID: 10601587
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs.
Parker WB; Cheng YC
Mol Pharmacol; 1987 Feb; 31(2):146-51. PubMed ID: 3807892
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the 3' --> 5' exonuclease of human DNA polymerase epsilon by fludarabine-terminated DNA.
Kamiya K; Huang P; Plunkett W
J Biol Chem; 1996 Aug; 271(32):19428-35. PubMed ID: 8702631
[TBL] [Abstract][Full Text] [Related]
40. Effects on human peripheral lymphocytes of in vivo administration of 9-beta-D-arabinofuranosyl-2-fluoroadenine-5'-monophosphate (NSC 312887), a new purine antimetabolite.
Boldt DH; Von Hoff DD; Kuhn JG; Hersh M
Cancer Res; 1984 Oct; 44(10):4661-6. PubMed ID: 6205751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
